MEDIUM-TERM PATENCY OF ARTERIOVENOUS FISTULA CREATION FOR HEMODIALYSIS IN PATIENTS WITH CHRONIC RENAL FAILURE

Đức Tín Lê, Thị Hiếu Văn , Thị Thùy Vy Trần

Main Article Content

Abstract

Background: In Vietnam, it is estimated that about 8 million people have chronic kidney failure, of which stages III to V account for 3.1 - 3.6% [3]. Today, hemodialysis is a popular method in the world, as well as in Vietnam. This is a method of filtering blood by creating a circulation outside the body to remove waste and excess water through the filter through the following mechanisms: ultrafiltration, diffusion, and convection. Most patients need dialysis 12-18 hours/week and usually three times/week. Arteriovenous bypass surgery for routine dialysis in patients with end-stage chronic kidney failure is essential. Methods: Retrospective description of case series. Results: The study had a mean age of 55.5 ± 15.1 years; Females make up the majority, and lipid metabolism disorders, hypertension, and diabetes account for 97.9%, 94%, and 79.2% of the sample, respectively. The surgical location of the wrist between the radial artery and cephalic vein accounted for the majority, 50.6% of the sample. We often ligate the returning venous branch after AVF surgery, accounting for 91.5% of the sample. The technical success rate reached 96.2%. The complications recorded as surgical wound infection accounted for 7.7%; hematoma accounted for 6.4%; and embolism 1.7%. The rate of primary patency accounted for 82.3% of the sample. Mid-term complications include steal syndrome, accounting for 10.6%; Hand edema accounted for 5.1% of the sample. Conclusion: The mid-term results in vascular primary patency of AVF in patients with chronic renal failure are safe, effective, and have few complications.

Article Details

References

1. William E.Mitch (2012). Chronic kidney disease, Gold n’s Medicine, 24th edition, 1, 810-818.
2. Andrew S Levey, Josef Coresh (2012). Chronic kidney disease, Lancet, 379, 165-180.
3. Vivekanand Jha (2009), Current status of chronic kidney disease care in Southest Asia,Seminars in Nephrology, 29(5),487-496.
4. Gjorgjievski N, Dzekova-Vidimliski P, Gerasimovska V, Pavleska-Kuzmanovska S, Gjorgievska J, Dejanov P, Sikole A, Ivanovski N. Primary Failure of the Arteriovenous Fistula in Patients with Chronic Kidney Disease Stage 4/5. Open Access Maced J Med Sci. 2019 Jun 15;7(11):1782-1787.
5. Nguyen B, Duong MC, Diem Tran HN, Do KQ, Nguyen KTT. Arteriovenous fistula creation by nephrologist and its outcomes: a prospective cohort study from Vietnam. BMC Nephrol. 2023 Apr 4;24(1):88.
6. Schmidli J, Widmer MK, Basile C, de Donato G, Gallieni M, Gibbons CP, et al. Editor’s choice – vascular Access: 2018 clini- cal practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55(6):757– 818.
7. McLafferty RB, Pryor RW, Johnson CM, Ramsey DE, Hodgson KJ. Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access. J Vasc Surg. 2007; 45(5):981-5.
8. Pfister M, d'Avalos LV, Müller PC, de Rougemont O, Bonani M, Kobe A, Puippe G, Nickel F, Rössler F. Long-term patency of arteriovenous fistulas for hemodialysis: A decade's experience in a transplant unit. Hemodial Int. 2023 Oct;27(4):388-399.
9. Huber TS, Carter JW, Carter RL, Seeger JM. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg. 2003 Nov;38(5):1005-11.
10. Hossain S, Sharma A, Dubois L, DeRose G, Duncan A, Power AH. Preoperative point-of-care ultrasound and its impact on arteriovenous fistula maturation outcomes. J Vasc Surg. 2018; 68(4):1157-1165.